MI2AMI-CS: A meta-analysis comparing Impella and IABP outcomes in Acute Myocardial Infarction-related Cardiogenic Shock.
Int J Cardiol
; 414: 132411, 2024 Nov 01.
Article
in En
| MEDLINE
| ID: mdl-39094635
ABSTRACT
BACKGROUND:
Cardiogenic Shock (CS) complicating acute myocardial infarction (AMI) poses a significant mortality risk, suggesting the opportunity to implement effective mechanical circulatory support strategies. The comparative efficacy of Intra-Aortic Balloon Pump (IABP) and Impella in managing CS-AMI remains a subject of investigation.OBJECTIVE:
This meta-analysis aims to evaluate the comparative effectiveness of Impella and IABP in managing CS-AMI, exploring mortality and adverse events.METHODS:
A systematic search of major databases from inception to November 2023 identified eight studies, comprising 10,628 patients, comparing Impella and IABP in CS-AMI. Retrospective studies (preferably Propensity-matched) and Randomized Clinical Trials (RCTs) were included.RESULTS:
Impella use exhibited significantly higher mortality (57% vs. 46%; OR 1.44, 95% CI 1.29-1.60; p < 0.001) and major bleeding (30% vs 15%; OR 2.93, 95% CI 1.67-5.13; p < 0.001).CONCLUSIONS:
In unselected CS-AMI patients, Impella usage is associated with significantly higher mortality and major bleeding.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Shock, Cardiogenic
/
Heart-Assist Devices
/
Intra-Aortic Balloon Pumping
/
Myocardial Infarction
Limits:
Humans
Language:
En
Journal:
Int J Cardiol
Year:
2024
Document type:
Article
Affiliation country:
Italy
Country of publication:
Netherlands